Nilius AM et al. |
Comparative in vitro activity of ABT-773, a novel antibacterial ketolide. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11408246
|
Lounis N et al. |
ATP synthase inhibition of Mycobacterium avium is not bactericidal. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19738016
|
Hamasuna R et al. |
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19738019
|
Peric M et al. |
Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604536
|
Odenholt-Tornqvist I et al. |
Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7695310
|
Rodvold KA et al. |
Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9174209
|
Fish DN et al. |
Penetration of clarithromycin into lung tissues from patients undergoing lung resection. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031063
|
Hirschl AM et al. |
In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858365
|
Bax HI et al. |
Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26883697
|
Aziz DB et al. |
Rifabutin Is Active against Mycobacterium abscessus Complex. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28396540
|
Jordan MK et al. |
Effects of fluconazole and clarithromycin on rifabutin and 25-O-desacetylrifabutin pharmacokinetics. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10898693
|
Kato M et al. |
Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10898707
|
Gustavson LE et al. |
Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8540719
|
Roblin PM et al. |
In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20038627
|
Chang HR and Pechère JC |
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2837140
|
Hammerschlag MR et al. |
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324650
|
Nagashima A et al. |
Clarithromycin Suppresses Chloride Channel Accessory 1 and Inhibits Interleukin-13-Induced Goblet Cell Hyperplasia in Human Bronchial Epithelial Cells. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27550358
|
Kosowska-Shick K et al. |
Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17116666
|
Kim IS et al. |
Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17116681
|
Morikawa K et al. |
Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7532933
|
Perronne C et al. |
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2171421
|
Goldstein EJ et al. |
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543769
|
Bui KQ et al. |
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471584
|
Sassa K et al. |
Therapeutic effect of clarithromycin on a transplanted tumor in rats. |
1999 |
Antimicrob. Agents Chemother. |
pmid:9869567
|
Gorzynski EA et al. |
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2524998
|
Meier A et al. |
Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192472
|
Loreto ES et al. |
New insights into the in vitro susceptibility of Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25223997
|
Chan GP et al. |
Clinical trial of clarithromycin for lepromatous leprosy. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203847
|
Onyeji CO et al. |
Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203849
|
Sassa K et al. |
Differential modulatory effects of clarithromycin on the production of cytokines by a tumor. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543765
|
Clark C et al. |
In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12183253
|
Tateda K et al. |
Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891128
|
Hunt Gerardo S et al. |
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891154
|
Fernandes PB et al. |
In vitro and in vivo activities of clarithromycin against Mycobacterium avium. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2530933
|
Alvarez A et al. |
Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19546360
|
Vance E et al. |
Pharmacokinetics of clarithromycin and zidovudine in patients with AIDS. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7574530
|
Koh WJ et al. |
Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23478956
|
Kohno Y et al. |
Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2526615
|
Khan R et al. |
T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15328128
|
van Zanten SJ et al. |
Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12821476
|
Debets-Ossenkopp YJ et al. |
Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756790
|
Kuo CC et al. |
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913488
|
Diacon AH et al. |
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22391540
|
Mor N and Heifets L |
MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431006
|
Tomioka H et al. |
In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431020
|
Rouse MS et al. |
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9257739
|
Pryjma M et al. |
Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the Gene. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28874379
|
Bolhuis MS et al. |
Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23689722
|
Conte JE et al. |
Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7726492
|
Ménard A et al. |
PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11897613
|
Nagai K et al. |
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600391
|
Friedman ND et al. |
Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26883709
|
Lazard T et al. |
Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684213
|
Emori M et al. |
Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684214
|
Chu SY et al. |
Absolute bioavailability of clarithromycin after oral administration in humans. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387301
|
Yajko DM et al. |
Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387302
|
Luna-Herrera J et al. |
Antituberculosis activity of clarithromycin. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8593004
|
Hardy RD et al. |
Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12709330
|
Tomioka H et al. |
Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11796367
|
Naik S and Ruck R |
In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2817858
|
Mathis A et al. |
Mitochondrial ribosome as the target for the macrolide antibiotic clarithromycin in the helminth Echinococcus multilocularis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16048933
|
Dai G et al. |
Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16048962
|
Phillips RO et al. |
Reply to "compliance with antimicrobial therapy for buruli ulcer". |
2014 |
Antimicrob. Agents Chemother. |
pmid:25225343
|
Klis S et al. |
Compliance with antimicrobial therapy for buruli ulcer. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25225342
|
Fish DN and Abraham E |
Pharmacokinetics of a clarithromycin suspension administered via nasogastric tube to seriously ill patients. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223952
|
Anton E et al. |
Randomized Trial of Clarithromycin for Mediterranean Spotted Fever. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26711765
|
Klemens SP et al. |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336945
|
Choi GE et al. |
Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22564831
|
Vaara M et al. |
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20479195
|
Heifets LB et al. |
Bacteriostatic and bactericidal activities of gentamicin alone and in combination with clarithromycin against Mycobacterium avium. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416852
|
Brown BA et al. |
Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416891
|
Biehle J and Cavalieri SJ |
In vitro susceptibility of Mycobacterium kansasii to clarithromycin. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416897
|
Chu SY et al. |
Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489187
|
Ishikawa C et al. |
Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19258275
|
Ji B et al. |
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878595
|
Hafner R et al. |
Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9517944
|
Fattorini L et al. |
Activities of isoniazid alone and in combination with other drugs against Mycobacterium avium infection in beige mice. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9517960
|
Heifets L |
Susceptibility testing of Mycobacterium avium complex isolates. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843278
|
Alper CM et al. |
Efficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843299
|
Falzari K et al. |
In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15793125
|
Rana KZ et al. |
Clarithromycin does not affect phosphorylation of zidovudine in vitro. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843311
|
Mougari F et al. |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27799212
|
Kutlin A et al. |
Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11796350
|
Ji B et al. |
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice? |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834894
|
Dattwyler RJ et al. |
Clarithromycin in treatment of early Lyme disease: a pilot study. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834900
|
Versalovic J et al. |
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834903
|
Alffenaar JW et al. |
Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20585115
|
Wallace RJ et al. |
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807061
|
Kishii K et al. |
In vitro activity of tebipenem, a new oral carbapenem antibiotic, against beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20585130
|
Gillum JG et al. |
Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807068
|
Hoffman HL et al. |
Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12543686
|
Spyridaki I et al. |
Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19332671
|
Lounis N et al. |
Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600387
|
Weiss S et al. |
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26392505
|
Gikas A et al. |
In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600400
|
Parra-Ruiz J et al. |
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20696880
|
Ji B et al. |
Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872741
|
Skinner PS et al. |
A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872747
|
Piccolomini R et al. |
Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9797240
|
Patel KB et al. |
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891147
|